Healthcare


 FDA Green Light Sparks Global Momentum for Orthocell’s Remplir™ Nerve Repair Device

FDA Green Light Sparks Global Momentum for Orthocell’s Remplir™ Nerve Repair Device

April 14, 2025 12:31 PM AEST| By Team Kalkine Media

Highlights,FDA clearance sets stage for U.S. entry into $1.6B nerve repair market,Manufacturing scaled to meet growing global demand,Strong cash reserves support expansion without extra funding,Orthocell (ASX:OCC) is entering a pivotal phase of growt...

 Neuren’s Next Big Step: FDA Clears Phase 3 Trial for Rare Disorder Treatment

Neuren’s Next Big Step: FDA Clears Phase 3 Trial for Rare Disorder Treatment

April 14, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,FDA clears path for Phase 3 trial in rare genetic disorder,Neuren's NNZ-2591 set for double-blind testing,Industry momentum grows for rare disease treatments,Neuren Pharmaceuticals (ASX:NEU) is making a significant stride in its drug devel...

 Emyria Expands Access to Psychedelic-Assisted Therapy with New Centre Launch in Perth

Emyria Expands Access to Psychedelic-Assisted Therapy with New Centre Launch in Perth

April 14, 2025 11:31 AM AEST| By Team Kalkine Media

Highlights,Emyria opens second mental health centre in Perth,Fully funded patient treatments begin,Plans aligned for national expansion,Emyria Ltd (ASX:EMD) is making significant strides in Australia’s mental health sector with the expansion of its p...

 Insiders Signal Confidence: Multiple Leaders Invest in SomnoMed Shares

Insiders Signal Confidence: Multiple Leaders Invest in SomnoMed Shares

April 14, 2025 11:29 AM AEST| By Team Kalkine Media

Highlights,Multiple insiders recently,acquired,shares in,SomnoMed,Largest insider purchase valued at AU$295k,Insider ownership stands at 7% of the company,Insider activity often offers unique insights into a company’s internal confidence. In the case...

 Neuren Pharmaceuticals Surges as FDA Greenlights Key Phase 3 Trial

Neuren Pharmaceuticals Surges as FDA Greenlights Key Phase 3 Trial

April 14, 2025 11:25 AM AEST| By Team Kalkine Media

Highlights,Neuren,gains FDA nod for crucial Phase 3 trial,Trial targets rare neurological disorder in children,Shares jump over 18% in early ASX trading,Shares of,Neuren Pharmaceuticals (ASX:NEU),rallied strongly on Monday, outperforming the broader...

 Visionflex Teams Up with Amplar Health in $1 Million Virtual Nursing Initiative

Visionflex Teams Up with Amplar Health in $1 Million Virtual Nursing Initiative

April 14, 2025 11:21 AM AEST| By Team Kalkine Media

Highlights,Visionflex,to deploy virtual nursing tech across aged care homes,$1 million contract spans hardware and software solutions,Project targets rural and culturally diverse communities,Visionflex Group Limited (ASX:VFX) has announced a binding...

 Cryosite’s Chairman Ups Stake: A Closer Look at Insider Moves (ASX:CTE)

Cryosite’s Chairman Ups Stake: A Closer Look at Insider Moves (ASX:CTE)

April 14, 2025 11:03 AM AEST| By Team Kalkine Media

Highlights,Cryosite’s,chairman,increases stake with recent purchase,Insider ownership,remains,significantly high at 61%,Mixed signals from past 12 months of insider activity,Cryosite Limited (ASX:CTE) has caught the attention of market watchers follo...

 Genetic Signatures Limited (ASX:GSS) Could Be Fairly Valued Despite a 30% Drop

Genetic Signatures Limited (ASX:GSS) Could Be Fairly Valued Despite a 30% Drop

April 12, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,Genetic Signatures (GSS) sees significant stock price decline.,Revenue growth outlook strong despite industry trends.,Market skepticism evident despite positive forecasts.,The journey has been rough for Genetic Signatures Limited (ASX:GSS)...

 Insider Dynamics of Monash IVF Group Limited (ASX:MVF)

Insider Dynamics of Monash IVF Group Limited (ASX:MVF)

April 12, 2025 12:30 PM AEST| By Team Kalkine Media

Highlights,Insider trades reveal confidence in Monash IVF despite share price drop.,Catherine Aston's significant stock purchase signals a positive outlook.,Monash IVF insiders own 1.2% of the company's shares, worth AU$3.4m.,In the world of investme...

 4DMedical’s Lung Imaging Tech Gains Global Traction in Breakthrough Respiratory Trials

4DMedical’s Lung Imaging Tech Gains Global Traction in Breakthrough Respiratory Trials

April 11, 2025 12:43 PM AEST| By Team Kalkine Media

Highlights,4DMedical partners with global firms on advanced lung disease therapies.,Software to support clinical trials for COPD and implantable lung,device,.,U.S. veterans’ healthcare initiative integrates 4DMedical’s diagnostic tech.,4DMedical’s (A...

 EBOS Group Secures $200M to Boost Global Expansion Plans

EBOS Group Secures $200M to Boost Global Expansion Plans

April 11, 2025 12:12 PM AEST| By Team Kalkine Media

Highlights,EBOS raises $200 million through equity placement,Funds to support recent acquisitions and growth,Additional $50 million targeted via retail offer,Healthcare and animal care products distributor EBOS Group (ASX:EBO) has successfully raised...

 Legal Heat Intensifies: Mayne Pharma Faces Contract Dispute Over 2022 Licensing Deal

Legal Heat Intensifies: Mayne Pharma Faces Contract Dispute Over 2022 Licensing Deal

April 11, 2025 10:59 AM AEST| By Team Kalkine Media

Highlights,Mayne Pharma embroiled in legal dispute with TherapeuticsMD,Allegations tied to a $153M women’s health portfolio deal,Legal claims include breach of contract and unjust enrichment,Mayne Pharma (ASX:MYX) is under scrutiny following legal ac...

 Is Investing in Trajan Group Holdings (ASX:TRJ) Considered Risky?

Is Investing in Trajan Group Holdings (ASX:TRJ) Considered Risky?

April 11, 2025 10:30 AM AEST| By Team Kalkine Media

Highlights,Examines Trajan Group Holdings' debt and financial health.,Highlights importance of managing liabilities without dilution.,Discusses risk factors related to Trajan Group's debt holdings.,Legendary fund manager Li Lu, famously backed by Cha...

 Argenica administers final doses to patients in acute ischemic stroke trial

Argenica administers final doses to patients in acute ischemic stroke trial

April 11, 2025 10:30 AM AEST| By Team Kalkine Media

Highlights,Argenica Therapeutics is conducting a Phase 2 trial evaluating ARG-007 for acute ischaemic stroke.,The trial involves a blinded comparison between ARG-007 and a saline placebo.,Topline results are expected to be released in the second half...

 Cyclopharm (ASX:CYC) experienced decline this week, which may be due to growing losses that could be causing concern among its investors.

Cyclopharm (ASX:CYC) experienced decline this week, which may be due to growing losses that could be causing concern among its investors.

April 10, 2025 10:32 PM AEST| By Team Kalkine Media

Highlights,Cyclopharm's share price dropped by 37% in the past year.,Market decline was around 2% for the same period.,Revenue growth for Cyclopharm was modest at 4.7%.,Investing in index funds can generally mirror market trends, but focusing on indi...

 EBOS Group (ASX:EBO) Gears Up for a Major $184 Million Equity Placement

EBOS Group (ASX:EBO) Gears Up for a Major $184 Million Equity Placement

April 10, 2025 06:10 PM AEST| By Team Kalkine Media

Highlights,EBOS Group (EBO) has temporarily paused trading.,A significant equity placement of NZ$200 million is underway.,Trading is set to resume by Friday following the placement's conclusion.,EBOS Group (ASX:EBO), a prominent player in the medical...

 Is Ramsay Health Care Limited's Recent Performance Driven by Poor Financials?

Is Ramsay Health Care Limited's Recent Performance Driven by Poor Financials?

April 10, 2025 04:30 PM AEST| By Team Kalkine Media

Highlights,Ramsay Health Care's stock has declined, reflecting concerns around profitability efficiency,Return on equity remains lower than the broader healthcare sector average,Dividend payout ratios have been historically high, limiting reinvestmen...

 4DMedical Showcases Lung Imaging Advancements to U.S. Congress

4DMedical Showcases Lung Imaging Advancements to U.S. Congress

April 10, 2025 03:30 PM AEST| By Team Kalkine Media

Highlights,4DMedical presented its advanced lung imaging technology to the U.S. Congress through a collaboration with Philips.,The company’s cardiopulmonary software transforms standard CT scans into detailed four-dimensional lung models.,Additional...

 Shopify Adopts AI-First Policy Before Approving Workforce Expansion

Shopify Adopts AI-First Policy Before Approving Workforce Expansion

April 10, 2025 03:16 PM AEST| By Team Kalkine Media

Highlights,Shopify mandates teams to prove tasks cannot be completed by AI before requesting additional hires,CEO emphasizes integrating autonomous AI agents into workflows across departments,Australia remains Shopify’s third-largest market with wide...

 Orthocell Expands Asia-Pacific Strategy with Hong Kong Submission for Remplir™

Orthocell Expands Asia-Pacific Strategy with Hong Kong Submission for Remplir™

April 10, 2025 03:13 PM AEST| By Team Kalkine Media

Highlights,Orthocell Ltd (ASX:OCC) has submitted a regulatory application in Hong Kong for its nerve repair product Remplir™,The company is expanding across Asia-Pacific following commercial traction in Australia, New Zealand, and Singapore,Orthocell...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.